Neurological Assessment of Hemodialysis Patients a Single Center Study

Abstract

Background Neurological impairment in patients with chronic kidney disease remains an important source of morbidity and mortality. Hemodialysis patients have not fully corrected neurological manifestations. This study was designed to conduct the prevalence of neurological manifestations among adult hemodialysis patients seen in the Nnephrology center of Medical City- Baghdad Teaching Hospital in the period from November 2011 to November 2012. Patients and Methods This was a prospective cross- sectional hospital based study. One hundred and four adult hemodialysis patients were included in the study using a simple, direct standardized questionnaire including history, systemic, neurological examinations, body weight and investigations like: Blood urea, serum creatinine, PCV%, and electrolytes. Results: Neurological disorders are common among patients on hemodialysis where weakness was the most common symptom and fine tremor was the most common sign. Most of the patients enrolled in the study had partially dependent gait. The duration that the patient is being on hemodialysis has a negative impact, and the neurological symptoms like headache, insomnia, fine tremor, proximal myopathy, distal myopathy, muscle cramps, weak/absent reflexes, peripheral neuropathy, postural hypotension, abnormal valsalva, nocturnal/post-prandial diarrhea and dependent gait were more common in patients whose spent more than one year on hemodialysis and the difference was statistically significant. The body mass index can affect some of the neurological manifestations and our study shows that there was a statistically significant difference in proximal weakness, distal weakness, weak/absent reflexes, peripheral neuropathy, postural hypotension, abnormal valsalva, dependent gait and partially dependent gait which are presented more in patients with BMI < 18.5 kg/m2. Patients with anemia (Hb<10 gm/dl) had more postural hypotension than those with (Hb>10 gm/d) and the difference statistically was significant while other neurological manifestations not. The hepatitis state of the patient has no impact on the neurological manifestations of the patients.

Authors and Affiliations

WASANMUNEAM MOHAMMED

Keywords

Related Articles

Development of Image Reconstruction Using Computed Tomography

The objective of this article is to understand the application of computing tomography scan in medicine, non-destructive testing/evaluation and to analyze the functioning of the internal body structures.

DESIGNING OF GLUTAMATE RECEPTOR INHIBITORS OF QUINAZOLINONE DERIVATIVES BY A COMPARATIVE QSAR ANALYSIS AND MOLECULAR MODELING STUDIES

An attempt was made to develop a two dimensional quantitative structure–activity relationship (2D-QSAR) and molecular docking studies on a series of quinazolinone derivatives acting as glutamate receptor inhibitors for c...

An Evaluation of Anti-Urolithiatic Activity of Polyherbal Formulation (Lithout Tablet) by In-Vitro Model

The aim of this study is to prepare & evaluate anti-urolithiatic activity of formulated polyherbal formulation (Lithout tablets) by in-vitro model. The study includes packing of drug and artificial calcium oxalate crysta...

Description of Nursing Shift Handover Implementation in One of Provincial Public Hospitals in DKI Jakarta Province

The nNursing handover has important consequences in the quality of nursing care to ensure continuity of care and patient safety. The purpose of this study was to describe the phenomenon related to nursing shift handover...

HYDROLYTIC DEGRADATION PROFILING OF EZETIMIBE BY HPLC METHOD

Background Forced degradation profiling is used to facilitate the development of analytical methodology, to gain a better understanding of active pharmaceutical ingredient (API) and drug product (DP) stability and it als...

Download PDF file
  • EP ID EP350293
  • DOI 10.24247/ijmpsapr20189
  • Views 93
  • Downloads 0

How To Cite

WASANMUNEAM MOHAMMED (2018). Neurological Assessment of Hemodialysis Patients a Single Center Study. International Journal of Medicine and Pharmaceutical Sciences (IJMPS), 8(2), 57-74. https://europub.co.uk/articles/-A-350293